ΛΟΙΠΟΙ ΚΛΑΔΟΙ

ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΕΤΑΙΡΕΙΕΣ

Έκδοση 1
Έτος Δημοσίευσης 2010
Χώρα Ελλάδα
Τιμή 471.00€

ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΕΤΑΙΡΕΙΕΣ

TABLE OF CONTENTS
1. Summary
1.1 Demand
1.2 Supply
1.3 The Market
1.4 The International and European Market
2. Sector Companies and Analysis of their Financial Data
2.1 Sales of Pharmaceutical Companies
2.2 Financial Analysis of Pharmaceutical Companies
Profitability
Performance
Liquidity
Financial Structure
Activity
Consolidated Balance Sheet
2.3 The Industry’s Credit Rating Migration
2.3.1 Companies’ Credit Rating Migration
2.3.2 Credit Rating Distribution of the Industry (Medicines – Cosmetics – Detergents) and Commerce (Medicines – Cosmetics – Detergents)
2.4 The Industry’s Transactional Behaviour Evolution
2.4.1 Transactional Behaviour of Assessed Businesses
2.4.2 Transactional Behaviour of the Industry (Medicines – Cosmetics – Detergents) and Commerce (Medicines – Cosmetics – Detergents)
Appendix to Chapter 2
3. Conclusions and Prospects for the Sector
General Overview
Analysis of the Competitive Environment
Threat of New Entrants
Threat of Substitute Products or Services
Bargaining Power of Suppliers
Bargaining Power of Customers
Competitive Rivalry within the Industry
SWOT Analysis
Financial Results
Prospects


TABLES
Table 2.1 Sales of Pharmaceutical Companies (2005-2009)
Table 2.2 Names and abbreviations of companies for graph reading (2.1–2.5)
Table 2.3 Creditworthiness of Assessed Businesses (2009-2008)
Table 2.4 INDUSTRY Credit Rating Distribution (Medicines – Cosmetics – Detergents) (2009)
Table 2.5 Commerce Credit Rating Distribution (Medicines – Cosmetics – Detergents) (2009)
Table 2.6 Transactional Behavior of the sector study companies (2009-2008)
Table 2.7 Industry Transactional Behavior of (Medicines – Cosmetics – Detergents) (2009-2008)
Table 2.8 Commerce Transactional Behavior of (Medicines – Cosmetics – Detergents) (2009-2008)
App 2.1 Definitions of financial ratios
App 2.2 Profitability ratios of pharmaceutical companies (2004-2008)
App 2.3 Performance ratios of pharmaceutical companies (2004-2008)
App 2.4 Liquidity ratios of pharmaceutical companies (2004-2008)
App 2.5 Financial structure ratios of pharmaceutical companies (2004-2008)
App 2.6 Activity ratios of pharmaceutical companies (2004-2008)
App 2.7 Consolidated balance sheet of pharmaceutical companies (2007-2008)
App 2.8 Consolidated balance sheets of profitable pharmaceutical companies (2007-2008)
App 2.9 Consolidated balance sheets of loss-making pharmaceutical companies (2007-2008)